Researchers Studied Two Alzheimer’s Groups. One Brain Difference Stood Out
Summary
A study of 66 people along the Alzheimer’s disease continuum found reduced glucose metabolism in similar brain regions across two patient groups. The biological factors linked to that reduction differed: tau-related measures in one group, and blood-brain barrier dysfunction and amyloid-related changes in the other.Key Facts
- The study included 66 people along the Alzheimer’s disease continuum and 41 cognitively healthy participants.
- Researchers divided patients into groups based on biomarkers for amyloid, tau and neurodegeneration.
- Both Alzheimer’s groups showed reduced glucose metabolism in temporoparietal brain areas involved in memory and cognitive processing.
- In the group with elevated tau biomarkers, glucose metabolism was associated with tau-related measures.
- In the group without elevated phosphorylated tau, poorer metabolism in posterior brain regions was associated with greater blood-brain barrier dysfunction and amyloid-related changes.
- The group without elevated phosphorylated tau had higher average cerebrospinal-fluid-to-serum albumin ratios, an indicator of blood-brain barrier impairment.
- The study’s findings were published in the journal Aging.
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.